openPR Logo
Press release

Defibrillators market is expected to reach USD 11.7billion by 2025 | Medtronic (Ireland), Abbott Laboratories (US), Boston Scientific (Germany), ZOLL Medical Corporation (US) etc.

03-20-2020 07:35 AM CET | Health & Medicine

Press release from: ReportsnReports

Defibrillators Market

Defibrillators Market

"The global defibrillators market is projected to grow at a CAGR of 3.4%"

The global defibrillators market is expected to reach USD 11.7billion by 2025 from USD 9.6 billion in 2019,at a CAGR of 3.4%.Factors such as the rising prevalence of target diseases, growing focus on providing public-access defibrillators, and training & awareness programs on defibrillators are expected to propel the growth of this market. However, issues related to the use of implantable and automated external defibrillators and frequent product calls are expected to restrain the growth of the defibrillators market in the forecast period. The defibrillators market has witnessed significant developments in terms of technological advancements and new product developments.

#Download Sample PDF Brochure of this latest Research Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=344031

The key players in the defibrillators market include Medtronic (Ireland), Abbott Laboratories (US), Boston Scientific (Germany), ZOLL Medical Corporation (US), Koninklijke Philips N.V. (Netherlands), BIOTRONIK (Germany), Nihon Kohden (Japan), MicroPort (China), Mediana (South Korea), CU Medical Systems (South Korea), Mindray Medical (China), Physio-Control (US),SCHILLER AG (Switzerland), Progetti Medical Equipment Solutions (Italy), and METsis Medikal (Turkey)

"The external defibrillators segment is expected to grow at the highest CAGR from 2019 to 2025"

On the basis of products, the defibrillators market is classified into implantable cardioverter defibrillators (ICDs) and external defibrillators. The ICDs product segment is further segmented into transvenous implantable cardioverter defibrillators (T-ICDs) and subcutaneous implantable cardioverter defibrillators (S-ICDs). The T-ICDs segment is further classified into single-chamber ICDs, dual-chamber ICDs, and cardiac resynchronization therapy defibrillators (CRT-Ds). The external defibrillators segment is further classified into external defibrillators, and wearable cardioverter defibrillators (WCDs). The external defibrillators segment is expected to grow at the highest CAGR in the forecast period, owing to factors such as the growing focus of key market players on developing easy-to-use defibrillators, increasing support from governments to install AEDs at public places, and rising adoption of WCDs.

"The hospitals, clinics, and cardiac centers segment to dominate the global defibrillators market during the forecast period"

On the basis of end users,the defibrillators market is segmented into hospitals, clinics, and cardiac centers; pre-hospital care settings; public access markets; alternate care facilities; and home care settings. The hospitals, clinics, and cardiac centers segment is estimated to account for the largest share of the defibrillators market in 2019. A growing number of cardiac implant procedures across the globe and the availability of reimbursements across the developed markets are some of the major factors driving the growth of this segment.

"APAC is projected to witness the highest growth during the forecast period"

The Asia Pacific defibrillators market is expected to grow at the highest CAGR from 2019 to 2025. Factors such as the rapidly growing aging population, increasing cases of cardiovascular diseases, improving research infrastructure, and growing focus of key market players to expand their presence in this region are driving the growth of the Asia Pacific defibrillators market.

#Download Sample PDF Brochure of this latest Research Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=344031

Research Coverage

This report studies the defibrillators market based on type, end user, and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It evaluates opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micro markets with respect to their growth trends, prospects, and contributions to the overall market. The report forecasts the revenue of the market segments with respect to four main regions.

Connect Us at sales@reportsandreports.com or call Us at 1-888-391-5441

About Us: ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Defibrillators market is expected to reach USD 11.7billion by 2025 | Medtronic (Ireland), Abbott Laboratories (US), Boston Scientific (Germany), ZOLL Medical Corporation (US) etc. here

News-ID: 1976935 • Views:

More Releases from ReportsnReports

DeviceCon Series 2024 - UK Edition | MarketsandMarkets
DeviceCon Series 2024 - UK Edition | MarketsandMarkets
Future Forward: Redefining Healthcare with Cutting-Edge Devices Welcome to DeviceCon Series 2024 - Where Innovation Meets Impact! Join us on March 21-22 at Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH for a groundbreaking convergence of knowledge, ideas, and technology. MarketsandMarkets proudly presents the DeviceCon Series, an extraordinary blend of four conferences that promise to redefine the landscape of innovation in medical and diagnostic devices. Register Now @ https://events.marketsandmarkets.com/devicecon-series-uk-edition-2024/register MarketsandMarkets presents
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Conference Promises New Trends and Insights in Diagnosis
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Confer …
London, March 7, 2024 - MarketsandMarkets is thrilled to announce the eagerly awaited 5th Annual Infectious Disease and Molecular Diagnostics Conference, scheduled to take place on March 21st - 22nd, 2024, at the prestigious Millennium Gloucester Hotel, located at 4-18 Harrington Gardens, London SW7 4LH. This conference promises to be a groundbreaking event, showcasing the latest trends and insights in diagnosis, as well as unveiling cutting-edge technologies that are revolutionizing the
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March 2024| Challenges and Factors affecting in Sterilization of medical devices and more
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March …
MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21-22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays. Enquire Now @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/ This conference aims to bring together all the stakeholders to discuss the obstacles in achieving
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, Surface and Forecast to 2025
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, S …
The global Breast Augmentation Market in terms of revenue was estimated to be worth $900 million in 2020 and is poised to reach $1,692 million by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying

All 5 Releases


More Releases for ICDs

Pacemakers & ICDs Market Segmentation: Identifying Key Segments for Growth
The global pacemakers and implantable cardioverter-defibrillators (ICDs) market is valued at approximately $10.5 billion in 2024, with a projected value reaching around $15 billion by 2034. This growth trajectory suggests a robust Compound Annual Growth Rate (CAGR) of about 4.5% during the forecast period from 2025 to 2034. Exactitude Consultancy., Ltd. released a research report offers a comprehensive examination of the various processes and materials used in the production of Pacemakers
Implantable Cardioverter Defibrillators (ICDs) Market Size Forecasted To Achieve …
Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics. What Is the Implantable Cardioverter Defibrillators (ICDs) Market Size and Projected Growth Rate? In recent times, the implantable cardioverter defibrillators (ICDs) market has seen significant growth. It is projected to escalate from $3.76 billion in 2024 to $3.99 billion in 2025, boasting a compound annual growth rate (CAGR) of 6.0%. The growth in the
Implantable Cardioverter Defibrillators (ICDs) Market Outlook 2025-2034: Key Tre …
What industry-specific factors are fueling the growth of the implantable cardioverter defibrillators (icds) market? The rise in cardiovascular diseases (CVDs) is predicted to fuel the expansion of the implantable cardioverter defibrillators (ICDs) market in the future. CVDs encompass a variety of ailments that impact the heart and blood vessels, including heart attacks, strokes, and hypertension, often triggered by unhealthy eating habits, physical inactivity, smoking, and hereditary factors. The escalating incidence of
Implantable Cardioverter Defibrillators (ICDs) Market by Product, End User, Type …
Implantable cardioverter defibrillators (ICDs) market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with the CAGR of 2.9% in the forecast period of 2021 to 2028. Industry Analysis Implantable cardioverter-defibrillator is a small battery-powered machine placed inside the body (chest) and it monitors the heart rhythm and detects the irregular heartbeats. It is capable of cardioversion,
Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revolutiona …
This report also researches and evaluates the impact of Covid-19 outbreak on the Pacemakers and Implantable Cardioverter Defibrillators (ICDs) industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Pacemakers and Implantable Cardioverter Defibrillators (ICDs) and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.). Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market Overview: The latest report on the global Pacemakers and Implantable
Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market to W …
LP INFORMATION recently released a research report on the Pacemakers and Implantable Cardioverter Defibrillators (ICDs) market analysis and elaborate the industry coverage, current market competitive status, and market outlook and forecast by 2025. Moreover, it categorizes the global Pacemakers and Implantable Cardioverter Defibrillators (ICDs)market by key players, product type, applications and regions,etc. The main objective of this market research is to help the readers understand the structure of Pacemakers and